An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 091579
Company: MACLEODS PHARMS LTD

Products on ANDA 091579

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
EFAVIRENZ	EFAVIRENZ	600MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 091579

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/10/2024	ORIG-1	Approval			Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/091579s000ltr.pdf

Therapeutic Equivalents for ANDA 091579

EFAVIRENZ

TABLET;ORAL; 600MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
EFAVIRENZ	EFAVIRENZ	600MG	TABLET;ORAL	Prescription	No	AB	077673	AUROBINDO PHARMA LTD
EFAVIRENZ	EFAVIRENZ	600MG	TABLET;ORAL	Prescription	No	AB	204766	CIPLA
EFAVIRENZ	EFAVIRENZ	600MG	TABLET;ORAL	Prescription	No	AB	078886	HETERO LABS LTD III
EFAVIRENZ	EFAVIRENZ	600MG	TABLET;ORAL	Prescription	No	AB	091579	MACLEODS PHARMS LTD
EFAVIRENZ	EFAVIRENZ	600MG	TABLET;ORAL	Prescription	No	AB	204869	PHARMOBEDIENT

Top